It is hypothesized that the COVID-19 pandemic had a major impact on the epidemiology of
malignant melanoma owing to diminished screening, diagnostic, and treatment capacities …

Non-melanoma carcinoma has high incidence rates and has two most common subtypes:
basal cell carcinoma and squamous cell carcinoma. This type of carcinoma is usually not …

Simple Summary Concerns about potential diagnostic delays due to pandemic-related
disruptions were expressed early during the COVID-19 outbreak. In the present study, we …

Background Cancer comprises a high burden on health systems. Performance indicators
monitoring cancer outcomes are routinely used in OECD countries. However, the …

Impact of the COVID-19 pandemic on melanoma diagnosis The magnitude of COVID-19's
effect on the timely management of melanoma and nonmelanoma skin cancers. We thank Dr …

Background The COVID‐19 lockdown had a dramatic impact on primary care access and
resulted in postponed skin cancer screenings. This raises concerns for a diagnostic delay on …

Background The COVID‐19 pandemic impacted Dutch society and the healthcare system.
Focus switched to care for COVID‐19 patients, thereby altering care for non‐COVID patients …

Background SARS‐CoV‐2 has massively changed the care situation in hospitals worldwide.
Although tumour care should not be affected, initial reports from European countries were …

Decreased numbers of new malignant melanoma (MM) cases, 1–4 increased tumour
thickness and occurrence of metastases of newly diagnosed melanomas 5, 6 in the time of …

The collateral damage caused by COVID-19 pandemic-associated public health and
governmental measures on patient care has been increasingly assessed in various …